SNU Open Repository and Archive: Browsing S-Space

Browse

S-Space

Browsing by Author Im, Young-Hyuck

Jump to a point in the index

Or type in a year

Sort by
In order
Results/Page
Authors/record

Showing results 1 to 11 of 11

Issue Date	Title / Author(s) / Citation	File
1999-12	Transcriptional repression of the transforming growth factor-β type I receptor gene by DNA methylation results in the development of TGF-β resistance in human gastric cancer Kang, Shin Hyeok; Bang, Yung-Jue; Im, Young-Hyuck; Yang, Han-Kwang; Lee, David A; Lee, Hwa Young; Lee, Ho Soon; Kim, Noe Kyeong; Kim, Seong-Jin Oncogene, Vol.18 No.51, pp.7280-7286	DOI
2000-04	Loss of TGF-β signaling contributes to autoimmune pancreatitis Hahm, Ki-Baik; Im, Young-Hyuck; Lee, Cecile; Parks, W. Tony; Bang, Yung-Jue; Green, Jeffrey E.; Kim, Seong-Jin Journal of Clinical Investigation, Vol.105 No.8, pp.1057-1065	DOI
2002	Importance of open lung biopsy in the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies Kim, Kihyun; Lee, Mark H.; Kim, Jingook; Lee, Kyung Soo; Kim, Sung Min; Jung, Man Pyo; Han, Joungho; Sung, Ki Woong; Kim, Won Seog; Jung, Chul Won; Yoon, Sung Soo; Im, Young-Hyuck; Kang, Won Ki; Park, Keunchil; Park, Chan Hyung Am J Hematol 2002;71:75-79	link
2002-03	Attenuation of transforming growth factor beta-induced growth inhibition in human hepatocellular carcinoma cell lines by cyclin D1 overexpression Jong, Hyun-Soon; Lee, Ho Soon; Kim, Tae You; Im, Young-Hyuck; Park, Jae-Won; Kim, Noe Kyeong; Bang, Yung-Jue Biochemical and Biophysical Research Communications, Vol.292 No.2, pp.383-389	link
2005-08	Docetaxel plus epirubicin as first-line chemotherapy in MBC (KCSG 01-10-05): Phase II trial and the predictive values of circulating HER2 extracellular domain and vascular endothelial growth factor Im, Seock-Ah; Kim, Sung-Bae; Lee, Moon Hee; Im, Young-Hyuck; Lee, Kyung Gee; Song, Hong-Suk; Lee, Myung-Ah; Lee, Junglim; Lee, Nam-Su; Ham, Hae Sun; Kim, Tae-You; Park, Yeon Hee; Lee, Kyung Eun; Kim, Kee Won; Seo, Jae Hong; Lee, Soon Nam; Hong, Young Seon; Bang, Yung-Jue; Kim, Woo-Kun; Park, Hee-Sook Oncology Reports, Vol.14 No.2, pp.481-487	DOI
2009-04	Cost-effectiveness analysis of adjuvant therapy for node positive breast cancer in Korea: docetaxel, doxorubicin and cyclophosphamide (TAC) versus fluorouracil, doxorubicin and cyclophosphamide (FAC) Lee, Sang Gyu; Jee, Young Geon; Chung, Hyun Chul; Kim, Sung-Bae; Im, Young-Hyuck; Seo, Jae Hong; Im, Seock-Ah; Ro, Jungsil BREAST CANCER RESEARCH AND TREATMENT; Vol.114 3; 589-595	DOI
2010-09	Triple-negative, basal-like, and quintuple-negative breast cancers: better prediction model for survival Choi, Yoon-La; Oh, Ensel; Park, Sarah; Kim, Yeonju; Park, Yeon-Hee; Song, Kyoung; Cho, Eun Yoon; Hong, Yun-Chul; Choi, Jong Sun; Lee, Jeong Eon; Kim, Jung Han; Nam, Seok Jin; Im, Young-Hyuck; Yang, Jung-Hyun; Shin, Young Kee BMC Cancer; Vol.10; 507	view file DOI
2010-09	Triple-negative, basal-like, and quintuple-negative breast cancers: better prediction model for survival Choi, Yoon-La; Oh, Ensel; Park, Sarah; Kim, Yeonju; Park, Yeon-Hee; Song, Kyoung; Cho, Eun Yoon; Hong, Yun-Chul; Choi, Jong Sun; Lee, Jeong Eon; Kim, Jung Han; Nam, Seok Jin; Im, Young-Hyuck; Yang, Jung-Hyun; Shin, Young Kee BMC Cancer, 10(1):507	view file DOI
2010-09	Triple-negative, basal-like, and quintuple-negative breast cancers: better prediction model for survival Choi, Yoon-La; Oh, Ensel; Park, Sarah; Kim, Yeonju; Song, Kyoung; Hong, Yun-Chul; Lee, Jeong Eon; Nam, Seok Jin; Yang, Jung-Hyun; Shin, Young Kee; Im, Young-Hyuck; Kim, Jung Han; Choi, Jong Sun; Cho, Eun Yoon; Park, Yeon-Hee BMC CANCER; Vol.10 ;507	view file DOI
2011-01	High serum TGF-alpha predicts poor response to lapatinib and capecitabine in HER2-positive breast cancer Rhee, Jiyoung; Han, Sae-Won; Cha, Yongjun; Ham, Hye Seon; Kim, Hwang-phill; Oh, Do-Youn; Im, Seock-Ah; Park, Jong-Wan; Ro, Jungsil; Lee, Keun Seok; Park, In Hae; Im, Young-Hyuck; Bang, Yung-Jue; Kim, Tae-You Breast Cancer Research and Treatment, Vol.125 No.1, pp.107-114	DOI
2019-05	Quality of life outcomes including neuropathy-associated scale from a phase II, multicenter, randomized trial of eribulin plus gemcitabine versus paclitaxel plus gemcitabine as first-line chemotherapy for HER2-negative metastatic breast cancer: Korean Cancer Study Group Trial (KCSG BR13-11) Kim, Ji-Yeon; Park, Seri; Im, Seock-Ah; Kim, Sung-Bae; Sohn, Joohyuk; Lee, Keun Seok; Chae, Yee Soo; Lee, Ki Hyeong; Kim, Jee Hyun; Im, Young-Hyuck; Kim, Tae-Yong; Lee, Kyung-Hun; Ahn, Jin-Hee; Kim, Gun Min; Park, In Hae; Lee, Soo Jung; Han, Hye Sook; Kim, Se Hyun; Jung, Kyung Hae; Park, Yeon Hee Cancer Communications. 39(1):29	view file DOI

1

Seoul National University Library, 1 Gwanak-ro, Gwanak-gu, Seoul 08826, Korea TEL: 02-880-5567 Email: s-space@snu.ac.kr

RSS 1.0 RSS 2.0 Atom

Hello

Browse

News About S-Space Seoul National University Library MY DSPACE LOGOUT LOGIN